WALD Key Statistics, Chart & Performance
The current stock price of WALD is 1.88 USD. In the past month the price decreased by -19.66%. In the past year, price decreased by -45.19%.
WALD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 62.33 | 37.74B | ||
| KVUE | KENVUE INC | 16.12 | 33.05B | ||
| ELF | ELF BEAUTY INC | 24.61 | 4.52B | ||
| BRBR | BELLRING BRANDS INC | 12.32 | 3.20B | ||
| IPAR | INTERPARFUMS INC | 16.19 | 2.72B | ||
| COTY | COTY INC-CL A | 16.21 | 2.69B | ||
| OLPX | OLAPLEX HOLDINGS INC | 16.75 | 894.46M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.71 | 792.14M | ||
| BNKK | BONK INC | N/A | 478.54M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.97 | 468.97M | ||
| NATR | NATURES SUNSHINE PRODS INC | 22.96 | 377.65M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.02 | 358.84M |
Related stock screener links
About WALD
Company Profile
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Company Info
WALDENCAST PLC-A
Michelin House, 81 Fulham Road
London NEW YORK GB
CEO: Michel Brousset
Employees: 332
Phone: 442031960264
WALDENCAST PLC-A / WALD FAQ
Can you describe the business of WALDENCAST PLC-A?
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
What is the current price of WALD stock?
The current stock price of WALD is 1.88 USD. The price decreased by -4.08% in the last trading session.
Does WALDENCAST PLC-A pay dividends?
WALD does not pay a dividend.
How is the ChartMill rating for WALDENCAST PLC-A?
WALD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting WALD stock to perform?
12 analysts have analysed WALD and the average price target is 3.26 USD. This implies a price increase of 73.62% is expected in the next year compared to the current price of 1.88.
What is the Price/Earnings (PE) ratio of WALDENCAST PLC-A (WALD)?
WALDENCAST PLC-A (WALD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.39).
Would investing in WALDENCAST PLC-A be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on WALD.
WALD Technical Analysis
WALD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to WALD. WALD may be in some trouble as it scores bad on both profitability and health.
WALD Financial Highlights
Over the last trailing twelve months WALD reported a non-GAAP Earnings per Share(EPS) of -0.39. The EPS increased by 60.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.32% | ||
| ROE | -8.5% | ||
| Debt/Equity | 0.33 |
WALD Forecast & Estimates
12 analysts have analysed WALD and the average price target is 3.26 USD. This implies a price increase of 73.62% is expected in the next year compared to the current price of 1.88.
For the next year, analysts expect an EPS growth of -514.69% and a revenue growth 3.09% for WALD